The aim of the study was to compare the effects of 2 strategies of antiplatelet treatment ( i.e. , 150 mg ASA vs. 75 mg clpoidogrel ) on plasma level of inflammatory markers in type 2 diabetes mellitus ( T2DM ) patients with high platelet reactivity ( HPR ) .